指标 | ω-3+胸腺肽α1组(n = 34) | ω-3组(n = 32) | 对照组(n = 30) | |||
治疗前 | 治疗后8 d | 治疗前 | 治疗后8 d | 治疗前 | 治疗后8 d | |
白蛋白 [M(Q1, Q3), g/L] | 31.52 (25.21, 36.32)a | 36.73 (29.13, 38.81)bcd | 31.31 (25.62, 37.13)a | 34.12 (27.61, 37.82)bd | 31.83 (25.53, 36.53)a | 33.42 (26.12, 37.71) |
Cr [M(Q1,Q3), μmol/L] | 72.73 (65.78, 206.26)a | 72.52 (65.21, 201.32) | 78.52 (65.21, 221.32)a | 78.45 (65.14, 236.17) | 76.86 (65.77, 236.32)a | 76.79 (64.23, 262.32) |
OI [M(Q1, Q3)] | 249.51 (182.24, 302.26)a | 271.55 (232.76, 303.72)bcd | 243.32 (180.56, 293.43)a | 262.33 (217.82, 295.26)bd | 244.56 (178.54, 278.73)a | 247.74 (204.57, 281.26) |